Inconclusive Bone Scan in Men with Intermediate and High-risk Prostate Cancer: What next?
metastasis
metastatic
prostatic cancer
radionuclide scan
skeletal scintigraphy
Journal
Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
23
7
2020
medline:
12
10
2021
entrez:
23
7
2020
Statut:
ppublish
Résumé
To evaluate the incidence of inconclusive bone scans and down-stream imaging and clinical follow-up generated, including subsequent treatment outcomes in men affected by inconclusive bone scans with intermediate- and high-risk prostate cancer. Retrospective study of clinical data for a Scottish population of men diagnosed with prostate cancer in the intermediate and high-risk groups. Of the 1,246 patients included, initially 81 men were identified as having an inconclusive bone scan result following multidisciplinary team discussion. After further imaging, 24 patients remained inconclusive for metastasis. Of these, two patients received no treatment; one because of a watchful waiting decision, and one because of death. Of the 13 patients receiving radical treatment (laparoscopic radical prostatectomy or radiotherapy), three patients showed relapse (23%) indicating presence of microscopic disease and failure of radical treatment alone for these patients. This paper will assist nurses and multidisciplinary team members in understanding how patients diagnosed with intermediate- and high-risk prostate cancer with inconclusive bone scan results are subsequently imaged and managed in the current health care system. This raises awareness amongst nursing staff of disease recurrence and the possibility of downstream multimodality treatment for these men with inconclusive bone scans.
Identifiants
pubmed: 32693961
pii: S0749-2081(20)30061-9
doi: 10.1016/j.soncn.2020.151046
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
151046Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.